North Korean imports of antibiotics spiked in April, Chinese trade data shows
China exported 15,000 kg of tetracycline derivatives, cited as a possible treatment for COVID-19, to the DPRK last month
As the world grappled with the COVID-19 outbreak in April, Chinese medicine exports to the DPRK remained largely stable, with one notable exception: tetracycline derivatives.
The shipment of over 15,000 kg in April represented a substantial spike compared to the zero imports in March and only 2550 kg in the combined January-February trade data from China’s General Administration of Customs (GAC).
Tetracyclines are a type of antibiotic generally agreed upon by doctors to represent a second-class drug, due to undesirable side effects and established bacterial resistance.
But they are preferred for specific infections, and
- 01North Korea in June 2020: a month in review and what’s ahead
- 02Some progress on long-stalled Pyongyang housing blocks under new campaign
- 03Sitting above rank: the rise of Ri Pyong Chol, Pak Jong Chon, and the military
- 04Secret partner: North Korean in Thailand behind network of money-making entities
- 05North Korean think tank statement shows focus on U.S. ‘hostile policy’ prevails
- 06Volte-face: What explains Kim Jong Un’s sudden change of heart?
- 07North Korea’s Central Military Commission: Kim Jong Un promotes a new generation
- 08Motivations for mass leafleting: What next for inter-Korean tensions?